Inhibrx Biosciences, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Inhibrx Biosciences, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Q2 2025

Aug 12, 2025

Earnings release8-K

2024

Q4 2024

Mar 16, 2025

Annual report10-K

2023

Q4 2023

Feb 28, 2024

Annual report10-K

2022

Q4 2022

Mar 6, 2023

Annual report10-K

2021

Q4 2021

Feb 28, 2022

Annual report10-K

2020

Q4 2020

Mar 12, 2021

Annual report10-K